Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

At our Medtech & Services Investor Lunch in Zurich, our portfolio managers Stefan Blum and Marcel Fritsch explained why the medtech sector may be poised for a comeback. finews.asia highlights the key takeaways – from strong fundamentals and attractive valuations to innovation and demographic trends.

Why Bellevue sees Medtech stocks making a comeback

At our Medtech & Services Investor Lunch in Zurich, our portfolio managers Stefan Blum and Marcel Fritsch explained why the medtech sector may be poised for a comeback. finews.asia highlights the key takeaways – from strong fundamentals and attractive valuations to innovation and demographic trends.
04.09.2026